|
| 36454220 | Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis. | Journal of Adolescent and Young Adult Oncology | 2023 |
| 35980483 | Osteosarcoma pre-diagnosed as another tumor: a report from the Cooperative Osteosarcoma Study Group (COSS). | Journal of Cancer Research and Clinical Oncology | 2023 |
| 37733117 | Solid pseudopapillary neoplasms of the pancreas in childhood and adolescence-an analysis of the German Registry for Rare Pediatric Tumors (STEP). | Eur J Pediatr | 2023 |
| 37909999 | Osteosarcoma Arising After Ewing Sarcoma or : A Report of 20 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS). | | 2023 |
| 37725766 | Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry. | J Clin Oncol | 2023 |
| 37548393 | Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group. | | 2023 |
| 36842425 | Osteosarcomas in older adults: A report from the Cooperative Osteosarcoma Study Group. | | 2023 |
| 36900310 | Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS). | | 2023 |
| 37379234 | Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome. | Neuro Oncol | 2023 |
| 36928868 | Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group. | | 2023 |
| 35195899 | Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults. | Cancer | 2022 |
| 35974385 | Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry. | J Hematol Oncol | 2022 |
| 36191386 | Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS). | Eur J Cancer | 2022 |
| 35338758 | Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS). | Pediatric Blood and Cancer | 2022 |
| 34880679 | Current Insights into the Management of Late Chemotherapy Toxicities in Pediatric Osteosarcoma Patients. | Cancer Management and Research | 2021 |
| 32179705 | Germline <i>RET</i> variants underlie a subset of paediatric osteosarcoma. | J Med Genet | 2021 |
| 33990016 | Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study. | Eur J Cancer | 2021 |
| 33549644 | The role of combined ion-beam radiotherapy (CIBRT) with protons and carbon ions in a multimodal treatment strategy of inoperable osteosarcoma. | Radiotherapy and Oncology | 2021 |
| 34383016 | Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report. | JAMA Oncol | 2021 |
| 31782150 | Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient-derived osteosarcoma cells and synergizes with cisplatin and talazoparib. | International Journal of Cancer | 2020 |
| 31507588 | Repertoire Sequencing of B Cells Elucidates the Role of UNG and Mismatch Repair Proteins in Somatic Hypermutation in Humans. | Front Immunol | 2019 |
| 31738425 | Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion. | Annals of Oncology | 2019 |
| 32223937 | Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion. | Annals of Oncology | 2019 |
| 29489754 | The landscape of genomic alterations across childhood cancers. | Nature | 2018 |
| 30013564 | No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency. | Front Immunol | 2018 |
| 27990273 | Advances in the management of osteosarcoma. | F1000Research | 2016 |
| 26632267 | Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency. | Nat Commun | 2015 |
| 25926029 | Establishment of a patient-derived orthotopic osteosarcoma mouse model. | J Transl Med | 2015 |
| 26178881 | Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy. | Radiat Oncol | 2015 |
| 23801068 | Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model. | Strahlenther Onkol | 2013 |
| 22249335 | Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation. | Strahlentherapie und Onkologie | 2012 |
| 23072718 | Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data. | Radiat Oncol | 2012 |
| 21933400 | Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines. | Radiation Oncology | 2011 |
| 20646843 | Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition. | Int J Radiat Oncol Biol Phys | 2010 |
| 20226028 | Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma. | BMC Cancer | 2010 |
| 20968138 | Radiotherapy in the treatment of primary osteosarcoma--a single center experience. | Tumori | 2010 |
| 20980873 | Seroreversion in vertically HIV-1-infected children treated early and efficiently: rule or exception? | AIDS | 2010 |
| 19378321 | Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome. | Genes Chromosomes Cancer | 2009 |
| 19393287 | SELDI-TOF MS detection of urinary hepcidin. | | 2009 |